New-onset atrial fibrillation following percutaneous patent foramen ovale closure: a systematic review and meta-analysis of randomised trials

EuroIntervention 2019;14:1788-1790 published online October 2018. DOI: 10.4244/EIJ-D-18-00767

Akram Elgendy
Akram Y. Elgendy1*, MD; Islam Y. Elgendy1, MD; Mohammad K. Mojadidi1, MD; Ahmed N. Mahmoud1, MD; Julia S. Barry1, DO; Hani Jneid2, MD; Siddharth A. Wayangankar1, MD; Jonathan M. Tobis3, MD; Bernhard Meier4, MD
1. Division of Cardiovascular Medicine, Department of Medicine, University of Florida, Gainesville, FL, USA; 2. Division of Cardiovascular Medicine, Baylor College of Medicine, Houston, TX, USA; 3. Division of Cardiology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, USA; 4. Department of Cardiology, University Hospital of Bern, Bern, Switzerland

Prior studies have shown that percutaneous patent foramen ovale (PFO) closure increases the risk of atrial fibrillation and atrial flutter (AF)1-5. Therefore, we sought to evaluate systematically the incidence of new-onset AF post percutaneous PFO closure and to determine the risk of stroke associated with new-onset AF.

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Interventions for strokeOther stroke interventions
Read next article
Is transcatheter aortic valve implantation feasible in patients with chronic kidney disease?

Latest news